Amgen: annual EPS forecast under consensus.
(CercleFinance.com) - Amgen reported this Wednesday before Wall Street opening that it had generated net profits of 2.
15 billion dollars in the second quarter of its financial year, or 2.91 dollars per share compared with 1.87 billion, or 2.47 dollars per share a year previously.
The American biotech firm's adjusted earnings per share (EPS) is 3.27 dollars, 11 cents more than consensus.
Turnover increased by 2% to come to 5.8 billion dollars, also trumping the average estimate from analysts of 5.67 billion.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
15 billion dollars in the second quarter of its financial year, or 2.91 dollars per share compared with 1.87 billion, or 2.47 dollars per share a year previously.
The American biotech firm's adjusted earnings per share (EPS) is 3.27 dollars, 11 cents more than consensus.
Turnover increased by 2% to come to 5.8 billion dollars, also trumping the average estimate from analysts of 5.67 billion.
Copyright (c) 2017 CercleFinance.com. All rights reserved.